Powered by lexis nexis

WuXi AppTec Lab Testing Division's Bioanalytical Service Unit Passed FDA Inspection

Feb 28, 2017 - PR Newswire

WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform company, today announced that its Lab Testing Division(LTD)'s Bioanalytical facility in Shanghai once again passed US FDA's bioequivalence (BE) inspection with no 483 observations.

The inspectors from FDA thoroughly audited WuXi's quality system during the 5-day inspection, focusing on scientific data integrity, operation infrastructure, equipment, sample storage, a...